Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes

J Am Coll Cardiol. 2016 Apr 5;67(13):1653-1654. doi: 10.1016/j.jacc.2016.01.042.

Publication types

  • Letter
  • Multicenter Study
  • Observational Study

MeSH terms

  • Adjuvants, Pharmaceutic / administration & dosage
  • Adjuvants, Pharmaceutic / adverse effects
  • Adult
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / adverse effects
  • Brugada Syndrome* / diagnosis
  • Brugada Syndrome* / epidemiology
  • Brugada Syndrome* / therapy
  • Defibrillators, Implantable / adverse effects
  • Electric Countershock* / adverse effects
  • Electric Countershock* / methods
  • Electrocardiography / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Quinidine* / administration & dosage
  • Quinidine* / adverse effects
  • Spain / epidemiology
  • Ventricular Fibrillation* / diagnosis
  • Ventricular Fibrillation* / etiology
  • Ventricular Fibrillation* / prevention & control

Substances

  • Adjuvants, Pharmaceutic
  • Anti-Arrhythmia Agents
  • Quinidine